| Code | 98357 | ||||||||||
| MA number | 73/0234/03-S | ||||||||||
| Product Form: | gto por 1x25 ml (fľ.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 73 - SPASMOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | brown glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 25.07.2003 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| Dokument: |
DHPC_metamizol_06.12.2024.pdf
|
| PIL: |
PIL_ALGIFEN NEO_gto por_02_2025.pdf
|
| SPC: |
SPC_ALGIFEN NEO_gto por_02_2025.pdf
|
| Safety feature | Yes |
| Data update: | 22.02.2018 |
